DK0492164T3 - Terapeutisk middel til glaucoma indeholdende 2-phenyl-3-oxo-2H-1,4-benzothiazinderivater - Google Patents

Terapeutisk middel til glaucoma indeholdende 2-phenyl-3-oxo-2H-1,4-benzothiazinderivater

Info

Publication number
DK0492164T3
DK0492164T3 DK91120212.5T DK91120212T DK0492164T3 DK 0492164 T3 DK0492164 T3 DK 0492164T3 DK 91120212 T DK91120212 T DK 91120212T DK 0492164 T3 DK0492164 T3 DK 0492164T3
Authority
DK
Denmark
Prior art keywords
oxo
phenyl
therapeutic agent
benzothiazine derivatives
benzothiazine
Prior art date
Application number
DK91120212.5T
Other languages
Danish (da)
English (en)
Inventor
Shiro Mita
Eiichi Shirasawa
Original Assignee
Santen Pharmaceutical Co Ltd
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd, Daiichi Seiyaku Co filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK0492164T3 publication Critical patent/DK0492164T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK91120212.5T 1990-11-29 1991-11-26 Terapeutisk middel til glaucoma indeholdende 2-phenyl-3-oxo-2H-1,4-benzothiazinderivater DK0492164T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33333290 1990-11-29

Publications (1)

Publication Number Publication Date
DK0492164T3 true DK0492164T3 (da) 1996-06-24

Family

ID=18264932

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91120212.5T DK0492164T3 (da) 1990-11-29 1991-11-26 Terapeutisk middel til glaucoma indeholdende 2-phenyl-3-oxo-2H-1,4-benzothiazinderivater

Country Status (10)

Country Link
US (1) US6281208B1 (de)
EP (1) EP0492164B1 (de)
JP (1) JP2975962B2 (de)
KR (1) KR100190332B1 (de)
AT (1) ATE133863T1 (de)
CA (1) CA2056670C (de)
DE (1) DE69117030T2 (de)
DK (1) DK0492164T3 (de)
GR (1) GR3019195T3 (de)
TW (1) TW207952B (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5511986A (en) * 1985-03-19 1986-10-13 Santen Pharmaceutical Co. Ltd. 2-arylbenzothiazine derivatives
AU587057B2 (en) * 1985-07-29 1989-08-03 Santen Pharmaceutical Co. Ltd. 1,4-dihydro-3-oxo-2-(substituted phenyl)-benzothiazine derivatives
FR2585574B1 (fr) * 1985-07-31 1988-09-09 Corbiere Jerome Nouvelles compositions pharmaceutiques anti-glaucomateuses a base de 1,4-dihydropyridines et leur procede d'obtention
FR2593395A1 (fr) * 1986-01-28 1987-07-31 Corbiere Jerome Nouvelles compositions pharmaceutiques antiglaucomateuses a base de 3-acetoxy-5-(2-dimethylaminoethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepine-4-one ou d'un de ses sels et leur procede d'obtention

Also Published As

Publication number Publication date
CA2056670A1 (en) 1992-05-30
JP2975962B2 (ja) 1999-11-10
US6281208B1 (en) 2001-08-28
KR100190332B1 (ko) 1999-06-01
CA2056670C (en) 1998-05-26
JPH06219950A (ja) 1994-08-09
GR3019195T3 (en) 1996-06-30
EP0492164B1 (de) 1996-02-07
DE69117030T2 (de) 1996-07-18
ATE133863T1 (de) 1996-02-15
TW207952B (de) 1993-06-21
KR920009402A (ko) 1992-06-25
EP0492164A1 (de) 1992-07-01
DE69117030D1 (de) 1996-03-21

Similar Documents

Publication Publication Date Title
FR2673538B1 (fr) Composition a base de 3-[2-(dimethylamino)ethyl]-n-methyl-1h-indole-5 methanesulfonamide pour l'administration buccale.
NO950799L (no) Oralt administrerbare farmasöytiske preparater
FI963424A0 (fi) Menetelmä terapeuttisesti aktiivisten tiofeenisulfonamidien valmistamiseksi
HRP20000494B1 (en) Pharmaceutically active morpholinol
NO890075L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazoler.
MY105121A (en) Pharmaceutical composition for systemic transdermal administration.
ATE188119T1 (de) Heilmittel für wunden und hämorrhoiden
WO1999012570A3 (en) Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
NZ237309A (en) 1-(2-(4-morpholino)ethyl)-3-(arylcarbonyl)-indole derivatives and pharmaceutical compositions
CA2041417A1 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
ES2037829T3 (es) Agentes contra el glaucoma a base de tiofen sulfonamida.
CA2046069A1 (en) Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
DK0492164T3 (da) Terapeutisk middel til glaucoma indeholdende 2-phenyl-3-oxo-2H-1,4-benzothiazinderivater
DE69722610D1 (de) Neue Inhalationspräparate enthaltend CR 2039 (Andolast)
NO980058L (no) Opthalmiske preparater
SE9401087D0 (sv) New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
EP0503079A4 (en) Pyridazinone-substituted ethynylphenyl derivative and remedy for circulatory organ disease containing the same as active ingredient
DE69635775D1 (de) Medikament gegen pulmonale herzprobleme
SE9002659D0 (sv) New pharmaceutical formulations
EP0784973A3 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
DK0452809T3 (da) Terapautisk middel til pollakisuri, urgeinkontinens eller urininkontinens omfattende alfa-phenyl-alfa-pyridylalkansyrederivater
MX9203171A (es) Composiciones farmaceuticas para el tratamiento de la hipertension arterial.
NL930142I1 (nl) Nieuwe farmaceutisch aktieve 1,2,3,4,4a,5,10,10a-octahydrobenzo-(g)chinolinederivaten